Which uBiome product is right for you?

SmartGut

Doctor-ordered gut health test

SmartJane

Doctor-ordered women’s health test

Explorer

Discover your microbiome without the help of a doctor

Who is it for?

Patients with chronic gut conditions such as IBD or IBS, or symptoms such as gas, bloating or diarrhea.

Female patients with the need to know more about their own vaginal health and how to improve conditions, such as discharges or infections, through lifestyle or diet.

Designed for citizen scientists and academic researchers to conduct experiments relating to the microbiome

Doctor authorization required?

Yes

Yes

No

Where is it available?

US and Canada (other countries coming soon)

US and Canada (other countries coming soon)

203 countries and regions where online payments can be made with a credit card or PayPal

What is the price?

Fully or partially covered by most health insurance companies under “out-of-network” healthcare benefits. During current pilot period, any costs not covered by insurance will NOT be charged to patients.

Fully or partially covered by most health insurance companies under “out-of-network” healthcare benefits. During current pilot period, any costs not covered by insurance will NOT be charged to patients.

From $89 for one site to $399 for five sites.

Targeted at which body site(s)?

Gut microbiome exclusively

Vaginal microbiome

Gut, nose, oral, skin or genital microbiome.

Suitable for other sampling purposes?

SmartGut is solely for adult gut samples.

SmartJane is solely for adult vaginal samples

Yes! Sample kids, pets, home environment, etc.

Any age requirements?

Available to everyone aged 18 years and older.

Available to everyone aged 18 years and older.

Available to all ages, parental permission needed if under 18.

How is sample collected?

Easy self-sampling at home, takes under three minutes.

Easy self-sampling at home, takes under three minutes.

Easy self-sampling at home, takes under three minutes.

What do results show?

Detects beneficial and pathogenic microorganisms associated with specific infections, lifestyle choices, and gut conditions including Inflammatory Bowel Disease (IBD) and irritable bowel syndrome (IBS).

Detects beneficial and pathogenic microorganisms associated with specific infections, such as cervicitis, bacterial vaginosis or vaginitis.

Interactive online tools enable you to explore how your microbiome compares to others, and to monitor yourself over time.

Where does processing take place?

In our San Francisco laboratory, which is CLIA-certified and accredited by the College of American Pathologists (CAP), a standard only achieved by the top 3% of laboratories in the world.

In our San Francisco laboratory, which is CLIA-certified and accredited by the College of American Pathologists (CAP), a standard only achieved by the top 3% of laboratories in the world.

In our San Francisco laboratory, which is CLIA-certified and accredited by the College of American Pathologists (CAP), a standard only achieved by the top 3% of laboratories in the world.

Can you participate in scientific research?

Optionally enables you to anonymously participate in scientific research aimed at advancing understanding of the human microbiome.

Optionally enables you to anonymously participate in scientific research aimed at advancing understanding of the human microbiome.

Optionally enables you to anonymously participate in scientific research aimed at advancing understanding of the human microbiome.

 
Our Science

With over 50 scientists working on the uBiome team from universities including UCSF, Stanford, Harvard, UCSD, Cambridge (UK) and Oxford (UK), with a collective experience of hundreds of years in the microbiome industry and over 300 scientific papers, uBiome continues to break new ground scientifically.


Our scientific advances in artificial intelligence, machine learning, and statistical genetics, as well as the largest database of microbiomes in the world (gathered over five years from hundreds of thousands of people), allow us to create revolutionary clinical products.

 uBiome has six issued patents and 73 published pending patents. We also have 20 papers and presentations from our scientific team written during their tenure at uBiome.

uBiome’s scientific advisors, including MacArthur Genius Award Winner Dr. Joseph DeRisi, PhD; Dr. Atul Butte, MD, PhD; Dr. Pablo Valenzuela, PhD; Dr. George Church, PhD; and Dr. Joel Palefsky, MD have helped us to develop our methods and to amass unmatched scientific expertise.

Bloomberg video

The bacteria that live in the intestinal tract can affect digestion, weight gain, mood and how the body absorbs medicine.

uBiome, a Silicon Valley startup, has built a company around sequencing gut bacteria – which the founders think one day will become as common and as medically necessary as a blood test.

But it’s a long road to that future, especially with a test that asks people to swab their toilet paper. (Video by David Nicholson, Curtis Grout) (Source: Bloomberg)

Our AdvisorsBack to top

SCIENTIFIC ADVISORY BOARD

 

Dr.Jen Balkus, PhD.

Assistant Professor in the Departments of Epidemiology and Global Health at the University of Washington School of Public
Health

Dr. Olaf Bodamer, MD, PhD.

Park Gerald Chair in Genetics & Genomics Associate Chief of Genetics & Genomics Associate Professor, Boston Children’s
Hospital/Harvard Medical School

Dr. Atul Butte, MD, PhD.

Priscilla Chan and Mark Zuckerberg Distinguished Professor, Director, Institute for Computational Health Sciences, UCSF School
of Medicine

Dr. George Church, PhD.

Professor of Genetics, Harvard Medical School

Dr. Joseph DeRisi, PhD.

Professor, Howard Hughes Investigator MacArthur Genius Award Winner Dept. Biochemistry and Biophysics, UCSF School of Medicine

Dr.Sharon Donovan, PhD.

Professor and Melissa M. Noel Endowed Chair in Nutrition and Health, Division of Nutritional Sciences, University of Illinois at Urbana-Champaign

Dr.Elaine Hsiao, PhD.

Assistant Professor, De Logi Chair in Biological Sciences, Department of Integrative Biology & Physiology, UCLA

Dr.Liz Lipski, PhD, CCN, CNS, CHN.

Director of Academic Development, Nutrition & Integrative Health at the Maryland University of Integrative Health.

Dr.Sünje Pamp, PhD.

Associate Professor in Microbial Ecology and Infectious Diseases, Genomic Epidemiology, Technical University of Denmark

Dr. Joel Palefsky, MD.

Professor of Medicine, Department of Infectious Diseases at UCSF School of Medicine

Kathie Madonna Swift MS RDN LDN FAND

Co-Founder, Integrative and Functional Nutrition Academy

Dr. Pablo Valenzuela, PhD.

Emeritus Professor at UCSF Winner of the Chilean National Prize in Applied Sciences Co-founder of Chiron Corporation

MEDICAL ADVISORY BOARD

 

Dr. David Agus, MD.

Professor of Medicine and Engineering, University of Southern California Best Selling Author

Dr. Robynne Chutkan, MD.

Assistant Professor in the Division of Gastroenterology at Georgetown University Hospital, Washington, DC

Dr. Michael Docktor, MD.

Clinical Director of Innovation, Boston Children’s Hospital Leading Gastroenterologist

Dr. Jennifer Gardy, MD.

Senior Scientist (Genomics), BC Centre for Disease Control Canada Research Chair in Public Health Genomics Assistant Professor,
School of Population & Public Health, UBC; guest host on Discovery Channel’s Daily Planet.

Dr.Felice Gersh, MD.

Board Certified in OB/GYN and Integrative Medicine, Director of the Integrative Medical Group of Irvine

Dr. Alan Greene, MD.

Private Medical, Founding President of the Society for Participatory Medicine, recipient of the “Healthy Child Healthy World” Award, named “The Children’s Health Hero of the Internet” by Intel – CMO of uBiome

Dr.Joel Kahn, MD, FACC.

Author, The Plant Based Solution

Dr. Daniel Kraft, MD.

Physician-scientist, Founder & Chair, Exponential Medicine, IntelliMedicine

Dr. Tiffany Lester, MD.

Functional Medicine Physician, Medical Director Parsley Health San Francisco

Dr. Michael McNamara, MD.

Founder, Medical Director at Dr. McNamara Premium Healthcare

Dr.Amy Shah, MD.

Integrative Medicine, Named one of mindbodygreen’s Top 100 Women In Wellness to Watch in 2015

PublicationsBack to top

8 PUBLICATIONS BY UBIOME STAFF

 

2018 Planned Publications for Submission by uBiome Staff

  • Measures of reproducibility and quality control of microbiome analysis
  • Identification of trimethylamine-producing bacteria in stool sample from uBiome Explorer kit users using metagenomics
  • Pleiotropic effects of the human microbiome: Identifying key microbiome members that are associated with health phenotypes
  • Application of machine-learning on a large stool dataset to develop significance-indices
  • Joined forces: Geographic patterns of human forehead skin microbiome obtained by citizen scientists
  • Association between the consumption of yogurt and other fermented foods and human gut microbiome composition: a uBiomeTM cohort study
  • Bias-evading molecular abundance estimation in marker-gene sequence library preparation bias using Unique Molecular Identifiers
  • Systematic review and meta-analysis on associations between Irritable Bowel Syndrome (IBS) and microbiome composition

7 PUBLICATIONS USING UBIOME’S TECHNOLOGIES

Conferences & PresentationsBack to top

13 Conference Abstracts and Presentations

  • Rafael Araos, Juan A. Ugalde, Erika D’agata. Microbial disruption indices in the fecal microbiome predicting acquisition of multidrug-resistant organism in nursing homes. Open Forum Infectious Diseases (Vol 4). Abstract presented in IDWeek 2017, October 4-8th. San Diego, CA. USA.
  • Melissa Alegría-Arcos, Valeria Marquez-Miranda, Ingrid Araya Duran, Fernando Gonzalez-Nilo, Jessica Richman, Zachary S Apte, Daniel E Almonacid. Reengineering of TLR2 modulating peptides from the human microbiota as new drugs for metabolic diseases. XL Annual Meeting of the Biochemistry and Molecular Biology Society of Chile. September 25-29th 2017, Puerto Varas, Chile.
  • Daniel Almonacid. Defining healthy reference ranges for probiotic taxa in the human gut microbiome. 2017 Meeting International Scientific Association for Probiotics and Prebiotics. June 27-29th. Chicago, IL, USA.
  • Elisabeth M. Bik. A decade of studies on the human microbiome: challenges and promises
. Maintaining Oral Health: Lessons learned from our microbiota. May 11, 2017. Amsterdam, The Netherlands.
  • Daniel E. Almonacid, Elisabeth M. Bik, Laurens Kraal, Francisco J. Ossandon, Yelena V. Budovskaya, Juan Pablo Cardenas, Jessica Richman, Zachary S. Apte. Healthy ranges for clinically important microbial taxa in the human gut. Keystone Symposium Microbiome in Health and Disease, February 5-9, 2017. Keystone, CO, USA.
  • Elisabeth M. Bik, Daniel E. Almonacid, Laurens Kraal, Francisco J. Ossandon, Yelena V. Budovskaya, Juan Pablo Cardenas, Jessica Richman, Zachary S. Apte. Reference ranges of 28 clinically important microbial taxa in the healthy human gut. Kisaco Research Human Microbiome Congress. January 24-25, 2017. San Diego, CA, USA.
  • Daniel Almonacid. Sequence similarity networks: Phylogenomics tool for studying sequence relationships across large datasets. XXXVIII Annual Meeting of the Biochemistry and Molecular Biology Society of Chile. September 22-25, 2015. Puerto Varas, Chile.
  • Zac Apte. Your microbiome and citizen science, science at scale. XXXVIII Annual Meeting of the Biochemistry and Molecular Biology Society of Chile. September 22-25, 2015. Puerto Varas, Chile.
  • Juan Pablo Cardenas, Daniel Almonacid, Laurens Kraal, Francisco Ossandon, Yelena Budovskaya, Jessica Richman, Zachary Apte. 16S rRNA Gene Sequencing as a Clinical Diagnostic Aid for Gastrointestinal-related conditions. Second ISCB Latin America Student Council Symposium. November 19th, 2016. Buenos Aires, Argentina.
  • Juan Pablo Cárdenas. “La Materia Oscura De La Vida: Desde El Microbioma Humano A Los Extremófilos” (The Dark Matter of Life: From the Human Microbiome to Extremophiles). XVII Congreso Nacional de Estudiantes de Biología. September 6, 2016, Piura, Perú.
  • Jessica Richman. Could a citizen scientist win a Nobel Prize? TEDMed 2013. April 16-19th, 2013. Washington, DC. USA. [http://www.tedmed.com/talks/show?id=54786]
  • Jessica Richman. Citizen Science and the Microbiome. ASM General Meeting. May 18-21st, 2013. Denver, CO, USA.
  • Zachary Apte. Crowdsourcing the Microbiome. 8th International Conference on Genomics (ICG8). October 30 – November 1st, 2013. Shenzhen, China.
  • Two poster presentations at the Chilean Society for Microbiology (Nov 14-17, 2017).
    Rodrigo Ortiz: “Role of the Blautia genus in the modulation of lactose tolerance as a member of the human gut microbiota” Authors: Rodrigo Ortiz, Melissa Alegria, Felipe Melis, Patricia Vera-Wolf, Inti Pedroso, Juan A. Ugalde, José Pérez-Donoso, Daniel Almonacid, Jessica Richman, Zachary Apte.
    Patricia Vera-Wolf: “Signature of the nose microbiome across geographical and temporal changes” Authors: Patricia Vera-Wolf, Luis Leon, Felipe Melis, Rodrigo Ortiz, Daniel Almonacid, Juan A. Ugalde, Jessica Richman, Zachary Apte.
  • Two invited symposium talks at the Chilean Society for Microbiology (Nov 14-17, 2017)
    Elisabeth Bik. A decade of studies on the human microbiome: challenges and promises
    Juan A. Ugalde. Microbial diversity in urban environments: Interactions between humans the built environment

Community outreachBack to top

20 community outreach talks

  • Jessica Richman. Sequence Me: Taking Personal Genomics Mainstream.
    South by SouthWest Conference.
    Date to be determined. 2018. Austin, Texas.
  • Jessica Richman. Breakaway Business Models.
    Harvard Medical School. Precision Medicine 2017 Keynote Talk.
    June 21, 2017. Boston, MA.
  • Jessica Richman. Could a Citizen Scientist win a Nobel Prize?
    TEDMED.COM. TedTalk
    November 1-3, 2017. Palm Springs, CA
  • Jessica Richman. Seizing the Disruptive Opportunity.
    Fortune Brainstorm Health Event.
    November 2, 2016. San Diego, CA.
  • Jessica Richman.
    White House Demo Day.
    August 4, 2015. Washington, VA.
  • Jessica Richman. The Future of Research. Citizen Science!
    TEDXBRUSSELS.EU
    November 1, 2013. Brussels, Belgium
  • Jessica Richman. Sequencing the Human Microbiome with Citizen Science.
    Singularity University Executive Program. Metrogenomics Talk.
    May 13, 2013. Moffett Field, CA
  • Elisabeth M. Bik. The human microbiome: 
Our friends for life. (1) Taste of Science: Science Without the Jargon. October 12, 2017. San Francisco, CA, USA. (2) CalTech Pomona. January 5, 2017. Pomona, CA, USA. (3) November 10, 2016. California Academy of Sciences, San Francisco, CA, USA.
  • Catalina Valdivia. ”Estudiando el microbioma con herramientas informáticas y ciencia ciudadana” (Studying the microbiome with informatics tools and citizen science): Penta UC, Pontificia Universidad Católica de Chile. June 2, 2017. Macul, Chile.
  • Ricardo Castro. “Inteligencia Artificial en Biología” (Artificial Intelligence in Biology): San Juan Bautista School. October 6, 2017. Ñuñoa, Santiago, Chile.
  • Katia Soto, Araceli Cruz, Janet Torres. “Mi universo bacteriano” (My bacterial universe): (1) Manuel Bulnes Prieto Public School. October 19, 2017. Renca, Santiago, Chile. (2) Madre Bernarda Morín Public Preschool. August 28, 2017. Providencia, Santiago, Chile. (3) Abelardo Iturriaga Jamett Public Preschool for children with Language Disorders. August 8, 2017. Providencia, Santiago, Chile. (4) Cultural Center of Conchalí. June 29, 2017. Conchalí, Santiago, Chile.
  • Harold Nuñez. Microbiology articles at ChileCientifico.com: (1) Microbiota, desarrollo y crecimiento (Microbiota, development and growth), May 29, 2017. (2) Resistencia bacteriana a los antibióticos (Bacterial resistance to antibiotics), July 11, 2017. (3) Las bacterias del cielo (Bacteria from the sky), September 7, 2017. (4) Las bacterias me controlan (Bacteria control me), October 24, 2017.

PatentsBack to top

6 GRANTED PATENTS

  • US 9663831. Apte, Z. and Richman, J. Granted on May 30, 2017. Method and system for microbiome analysis. Assignee: uBiome, Inc. San Francisco, CA, U.S.
  • US 9703929. Apte, Z., Richman, J., Behbahani, S.R. and Almonacid, D. Granted on July 11, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Assignee: uBiome, Inc. San Francisco, CA, U.S.
  • US 9710606. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Granted on July 18, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Assignee: uBiome, Inc. San Francisco, CA, U.S.
  • US 9754080. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Granted on September 5, 2017. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions. Assignee: uBiome, Inc. San Francisco, CA, U.S.
  • US 9760676. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Granted on September 12, 2017. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions. Assignee: uBiome, Inc. San Francisco, CA, U.S.
  • US 9758839. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Granted on September 12, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features. Assignee: uBiome, Inc. San Francisco, CA, U.S.

 

50 PUBLISHED PATENT APPLICATIONS

  • US 2015/0211078 A1. Apte, Z. and Richman, J. Published on July 30, 2015. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2015/0211055 A1. Apte, Z. and Richman, J. Published on July 30, 2015. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2015/0213193 A1. Apte, Z. and  Richman, J. Published on July 30, 2015. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0224749 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 4, 2016. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0228003 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0232319 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0362738 A1. Apte, Z., Almonacid, D. and Richman, J.. Published on August 11, 2016. Method and system for sequencing in characterization of antibody binding behavior. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0230217 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0232280 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0232312 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0232313 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 11, 2016. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0314281 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 27, 2016.Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0319358 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on November 3, 2016. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0321416 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on November 3, 2016. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0342735 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on November 24, 2016. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0362742 A1. Apte, Z., Almonacid, D. and Richman, J. Published on December 15, 2016. Method and system for sequencing in characterization of antibody binding behavior. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0002432 A1. Apte, Z., Richman, J. and Almonacid, D. Published on January 5, 2017. Method and system for diagnostic testing. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0024527 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on January 26, 2017. Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0035346 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on February 9, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0038368 A1. Apte, Z., Saichek, N. and Richman, J. Published on February 9, 2017. Digital microfluidics system and method. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0039347 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on February 9, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0053061 A1. Almonacid, D., Apte, Z. and Richman, J. Published on February 23, 2017. Method and system for multiplex primer design. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0175172 A1. Apte, Z., Valdivia, C., Almonacid, D. and  Richman, J. Published on June 22, 2017. Method and system for characterizing mouth-associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0224748 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on August 4, 2017. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0228514 A1. Apte, Z., Valdivia, C., Almonacid, D. and  Richman, J. Published on August 10, 2017. Method and system for characterizing skin related conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0235902 A1. Almonacid, D., Apte, Z. and Richman, J. Published on August 17, 2017. Method and system for characterization of clostridium difficile associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2016/0259909 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on September 8, 2017. Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions . Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0262608 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 14, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0268045 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0268046 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0270268 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0270269 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0270270 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0270271 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0270272 A1. Apte, Z., Richman, J. and Almonacid, D. Published on September 21, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277843 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277844 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277845 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277846 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277847 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0277848 A1. Apte, Z., Almonacid, D. and Richman, J. Published on September 28, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0286612 A1. Apte, Z., Almonacid, D. and Richman, J. Published on October 5, 2017. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0286619 A1. Apte, Z., Almonacid, D. and Richman, J. Published on October 5, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0286620 A1. Apte, Z., Richman, J. and Almonacid, D. Published on October 5, 2017. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0298418 A1. Apte, Z., Almonacid, D. and Richman, J. Published on October 19, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0308657 A1. Apte, Z., Richman, J. and Almonacid, D. Published on October 26, 2017. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0308658 A1. Apte, Z., Richman, J. and Almonacid, D. Published on October 26, 2017. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0308659 A1. Apte, Z., Richman, J. and Almonacid, D. Published on October 26, 2017. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0308660 A1. Apte, Z., Richman, J. and Almonacid, D. Published on October 26, 2017. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • US 2017/0308669 A1. Apte, Z., Richman, J., Almonacid, D., Pedroso, I., Ugalde, J. and Ortiz, R. Published on October 26, 2017. Method and system for microbial pharmacogenomics. Applicant: uBiome, Inc. San Francisco, CA, U.S.

 

23 PUBLISHED INTERNATIONAL PATENT APPLICATIONS 

  • WO 2015/112352 A1.  Apte, Z. and Richman, J. Published on July 30, 2017. Method and system for microbiome analysis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/065075 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on april 28, 2016. Method and system for microbiome-derived diagnostics and therapeutics. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168370 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168364 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168359 A1.  Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168355 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168354 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168352 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168350 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168344 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168336 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/168316 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on October 20, 2016. Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2016/205416 A1. Apte, Z., Almonacid, D., Richman, J. and Behbahani, S.R. Published on December 22, 2016. Method and system for sequencing in characterization of antibody binding behavior. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/004379 A1. Apte, Z., Richman, J. and Almonacid, D. Published on January 5, 2017. Method and system for diagnostic testing. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044880 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics infectious disease and other health conditions associated with antibiotic usage. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044886 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044901 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044902 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for oral health. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044900 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with thyroid health issues. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044885 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/044871 A1. Apte, Z., Richman, J., Almonacid, D. and Behbahani, S.R. Published on March 16, 2017. Method and system for microbiome-derived diagnostics and therapeutics for eczema. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/100688 A1. Almonacid, D., Apte, Z. and Richman, J. Published on June 15, 2017. Method and system for characterization of clostridium difficile-associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.
  • WO 2017/156031 A1. Apte, Z., Valdivia, C., Almonacid, D. and  Richman, J. Published on  September 14, 2017. Method and system for characterizing mouth-associated conditions. Applicant: uBiome, Inc. San Francisco, CA, U.S.

FAQs

No newline at end of file